Drugging the undruggable: targeting challenging E3 ligases for personalized medicine.
about
Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation.Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-Welcome to Future Medicinal Chemistry volume 10.A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders.
P2860
Drugging the undruggable: targeting challenging E3 ligases for personalized medicine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Drugging the undruggable: targeting challenging E3 ligases for personalized medicine.
@en
type
label
Drugging the undruggable: targeting challenging E3 ligases for personalized medicine.
@en
prefLabel
Drugging the undruggable: targeting challenging E3 ligases for personalized medicine.
@en
P2860
P356
P1476
Drugging the undruggable: targeting challenging E3 ligases for personalized medicine.
@en
P2093
Carles Galdeano
P2860
P304
P356
10.4155/FMC-2017-0009
P577
2017-03-06T00:00:00Z